Skip to main content

Should lymphocyte predominance Hodgkin’s disease be treated like classical Hodgkin’s disease?

  • Chapter
Human Lymphoma: Clinical Implications of the REAL Classification
  • 60 Accesses

Abstract

Lymphocyte predominance Hodgkin’s disease differs from nodular sclerosis and mixed cellularity disease both clinically and histopathologically [47.1]. This chapter is concerned with the patterns of presentation, stage, median time to recurrence, pattern of late recurrences, the risk of secondary non-Hodgkin’s lymphomas, and the low mortality of this entity.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Selected References

  1. Trudel MA, Krikorian JG, Neiman RS. Lymphocyte predominance Hodgkin’s disease. A clinicopathologic reassessment. Cancer 1987; 59: 99–106.

    Article  CAS  PubMed  Google Scholar 

  2. Regula DP Jr., Hoppe RT, Weiss LM. Nodular and diffuse types of lymphocyte-predominance Hodgkin’s disease. N Engl J Med 1988; 318: 214–9.

    Article  PubMed  Google Scholar 

  3. Borg-Grech A, Radford JA, Crowther D, Swindell R, Harris M. A comparative study of the nodular and diffuse variants of lymphocyte predominant Hodgkin’s disease. J Clin Oncol 1989; 7: 1303–9.

    CAS  PubMed  Google Scholar 

  4. Tefferi A, Zellers RA, Banks PM, Therneau TM, Colgan JP. Clinical correlates of distinct immunophenotypic and histologic subcategories of lymphocyte-predominance Hodgkin’s disease. J Clin Oncol 1990; 8: 1959–65.

    CAS  PubMed  Google Scholar 

  5. Crennan E, D’Costa I, Liew KH et al. Lymphocyte predominant Hodgkin’s disease: a clinicopathologic comparative study of histologic and immunophenotypic subtypes. Int J Radiat Oncol Biol Phys 1995; 31: 333–7.

    Article  CAS  PubMed  Google Scholar 

  6. Pappa VI, Norton AJ, Gupta RK, Wilson AM, Rohatiner AZ, Lister TA. Nodular type of lymphocyte predominant Hodgkin’s disease. A clinical study of 50 cases. Ann Oncol 1995; 6: 559–65.

    CAS  PubMed  Google Scholar 

  7. Bodis S, Kraus MD, Pinkus G et al. Clinical presentation and outcome in lymphocyte-predominant Hodgkin’s disease. J Clin Oncol 1997; 15: 3060–6.

    CAS  PubMed  Google Scholar 

  8. Mauch PM, Kalish LA, Kadin M et al. Pattern of presentation of Hodgkin’s disease. Implications for etiology and pathogenesis. Cancer 1993; 71: 2062–71.

    Article  CAS  PubMed  Google Scholar 

Further Reading

  • Pinkus GS, Said JW. Hodgkin’s disease, lymphocyte predominance type, nodular — a distinct entity? Unique staining profile for L&H variants of Reed-Sternberg cells defined by monoclonal antibodies to leukocyte common antigen, granulocyte-specific antigen, and B-cell-specific antigen. Am J Pathol 1985; 118: 1–6.

    CAS  PubMed  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1999 Springer-Verlag London

About this chapter

Cite this chapter

Mauch, P.M. (1999). Should lymphocyte predominance Hodgkin’s disease be treated like classical Hodgkin’s disease?. In: Mason, D.Y., Harris, N.L. (eds) Human Lymphoma: Clinical Implications of the REAL Classification. Springer, London. https://doi.org/10.1007/978-1-4471-0857-3_47

Download citation

  • DOI: https://doi.org/10.1007/978-1-4471-0857-3_47

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-4471-1218-1

  • Online ISBN: 978-1-4471-0857-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics